6th Sep 2007 16:56
Skyepharma PLC06 September 2007 SkyePharma to Announce 2007 Interim Results on 20 September LONDON, UK, 6 September 2007 - As previously announced on 29 June 2007,SkyePharma PLC (LSE: SKP) confirms that it will issue its interim results forthe six months ended 30 June 2007 to the London Stock Exchange at 7.00 a.m. onThursday 20 September 2007. An analyst briefing will be given by Frank Condella (CEO) and Peter Grant(Finance Director) at the London offices of Financial Dynamics at 9.00 a.m. andwill be webcast live (audio and presentation only). Investors and otherinterested parties may view the live webcast via the Company's website atwww.skyepharma.com under the Investor Relations tab. For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has eleven approved products in the areas of oral,inhalation and topical delivery. The Group's products are marketed throughoutthe world by leading pharmaceutical companies. For more information, visit www.skyepharma.com Note to Analysts Please call Mo Noonan for further details of the presentation on 020 7269 7116or email [email protected]. Analysts may prefer to participate in thepresentation by conference call. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L